The Supreme Court ruled generic drug labeling alone cannot support patent inducement claims without clear, affirmative steps encouraging infringement.
The post SCOTUS News: Drugmaker’s ‘induced infringement’ suit comes up short appeared first on Michigan Lawyers Weekly.